Chroma Therapeutics
Ian Nicholson, currently director of business development at Celltech Group, has been appointed chief executive of Chroma Therapeutics, the drug discover group. In addition, Chroma announces that Raj Parekh, former founder of Oxford Glycosciences and later a director of Abingworth Management, the lead venture capital provider to Chroma, has been appointed chairman.